CIMBAN
Live / Registered — Registered (as of 27 May 2025)
What this means for you
Registered since 27 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98558902
- Registration number
- 7806705
- Mark type
- Stylized text
- Filed
- 20 May 2024
- Published for opposition
- 08 Apr 2025
- Registered
- 27 May 2025
- Attorney of record
- Jeffrey H. Greene
Goods and services
- Class 001 — Chemicals: Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; synthetic DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for use in medical biologics and therapeutics; Molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins.
- Class 042 — Scientific and technological services: Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; Genetic engineering services, namely, manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the design, development and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineering, namely, production of complex gene sequences; Consultancy, advisory and information services related to the aforementioned services; Software-as-a-Service (SaaS) services featuring software with a bioinformatics algorithm for use in designing gene assembly paths; Platform-as-a Service (PaaS) services featuring software platforms with a bioinformatics algorithm for use in designing gene assembly paths.
Owner
- Camena Bioscience Limited, SAFFRON WALDEN, Essex, GB
- Camena Bioscience Limited, SAFFRON WALDEN, Essex, GB
- Camena Bioscience Limited, SAFFRON WALDEN, Essex, GB
Prosecution history
- 27 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Dec 2024 — NON-FINAL ACTION E-MAILED
- 18 Dec 2024 — NON-FINAL ACTION WRITTEN
- 04 Dec 2024 — ASSIGNED TO EXAMINER
- 22 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 May 2024 — NEW APPLICATION ENTERED